Healio Gastroenterology Current Issue

The following articles appeared in the print edition of Healio Gastroenterology.

Table of Contents

• Bench to Bedside to Market and Back Again: Revolutionizing the Microbiome Katrina Altersitz
• Healio Gastroenterology and Liver Disease 200
• Obeticholic Acid Shows Fibrosis Improvement in NASH
• Budding Growth: Gottlieb Expanded GI Drug Approvals, Fostered Medical Cannabis Development
• Call to Action: One Email, Phone Call May Just Save a Life
• Annual FITs Effective for Colorectal Cancer Screening
• Antibiotics, PPIs Increase Risk for CDI in Hospitalized Children
• Childhood Exposure to Systemic Antibiotics Linked to Celiac Disease
• Comparative Study Finds Most Effective Bowel Preps
• Early Life Factors Linked to Later IBD Development
• FMT Safe for Patients With PSC, may Lower ALP
• Genetic Test Could Improve Safety of Thiopurine Treatment in IBD
• High-fat Diet Linked to Unfavorable gut Microbiota Changes
• Optimized Remicade Monotherapy Effective for IBD Induction
• Support Tool Helps Standardize Ulcerative Colitis Care
• Anti-TNFs Linked to new Onset Psoriasis in Pediatric IBD
• Data Support Controlled-release Cyclosporine to Treat Ulcerative Colitis
• Entyvio Superior to Humira in Moderate, Severe Ulcerative Colitis
• Etrasimod Induces Endoscopic, Histologic Improvement in UC
• HIV Drug Candidate Shows Promise in Ulcerative Colitis
• Intensive Treatment Within the First Year Prevents Early Crohn’s Progression
• Optimization Helps Patients With Crohn’s Recapture Stelara Response
• Upadacitinib Effective in UC Induction
• VIDEO: ‘Tying it all Together’ in IBD – Microbiome, Diet and Brain
• Breath Test has ‘Potential to Revolutionize’ Cancer Detection, Diagnosis
• Clostridioides difficile: What's in a Name?